ARCHIMED
Denis Ribon is the Chairman and Managing Partner at ARCHIMED, where Denis has been impacting healthcare since April 2014. Denis also serves as a Board Director at various companies, including Groupe CARSO, SUANFARMA, Prollenium, ImaBiotech, NAMSA, ActiGraph, Polyplus-transfection S.A. Denis's educational background includes a degree in Veterinary from VetAgro Sup, an MBA from HEC Paris, and a Baccalauréat in Mathematics from Sainte-Marie Lyon. Denis Ribon's expertise lies in various industries such as pharmaceuticals, biotechnology, and medical device testing.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.